Case Report: Facial Malassezia folliculitis following infliximab treatment in Crohn’s disease
Infliximab (IFX), a first-line treatment for moderate to severe Crohn’s disease (CD), has immunomodulatory effects that increase the risk of opportunistic infections. Although IFX-associated invasive fungal infections have received widespread attention…